Overall, FLGT stock price is still in a long-term downtrend. Today, FLGT stock is hovering around $31.4. The price has tested the nearest resistance at $38.5 and is bouncing down. The next strong support is at $16.
As a stock market expert, I am closely following the progress of Fulgent Genetics (FLGT), an entity providing genetic testing services. FLGT operates in an increasing niche industry due to the COVID-19 pandemic.
Genetic testing is rapidly advancing, with FLGT at the forefront. Their primary goal is to develop tests that can detect diseases and disorders based on a patient’s genetic makeup. This helps healthcare providers diagnose and treat patients more accurately, which is especially crucial given the rise in genetic-based conditions.
One of the most remarkable characteristics of FLGT is its agility and capacity to pivot quickly. When COVID-19 hit, they developed a test to detect it quickly – which enabled them to expand their revenue streams and capitalize on an unexpected surge in testing demand. FLGT’s quick response demonstrates its strong team and culture of innovation – both essential elements for long-term success within the genetic testing industry.
Another distinguishing characteristic of FLGT from its competitors is its use of advanced technology. They have created an exclusive platform, called Picture Genetics, which enables patients to order genetic tests online and receive accurate results quickly and precisely. This platform is user-friendly and accessible, giving patients all the information they need to make informed decisions about their healthcare options.
Overall, I believe FLGT has a bright future in the genetic testing industry. The company’s commitment to innovation, agility, and technology positions it well-positioned to capitalize on the growing demand for genetic testing services. However, like any investment decision, there are risks involved. As an experienced stock market expert I advise investors to conduct due diligence and thoroughly assess FLGT’s financials and business strategy before making any investment decisions.
